baber/WOPTO huggingface dataset:
Patent ES-2200738-T3 (ES)
Inventor: ELLER MARTIN
IPC: F23Q7/00
Filed: 2000-02-14
Granted: 2004-03-16
Abstract: The rod glow plug has a glow tube, internal heating coil(s) and if appropriate control coil(s) and a connecting pole leading into the tube, whereby the coil(s) is connected to the connecting pole and the tip of the glow tube. A stabiliser rod (10) is provided that extends through an opening in the tip of the glow tube from the connecting pole (9) to the tube tip in a mounting stage, and the stabiliser rod is arranged to pass essentially centrally through the coil(s) (7).
Patent ES-2235770-T3 (ES)
Inventor: PAU MARIA GRAZIA
IPC: A61K35/76
Filed: 2000-11-24
Granted: 2005-07-16
Abstract: Novel means and methods are provided for the production of mammalian viruses, comprising infecting a culture of immortalized human cells with the virus, incubating the culture infected with virus to propagate the virus under conditions that permit growth of the virus, and to form a virus-containing medium, and removing the virus-containing medium. <??>The viruses can be harvested and be used for the production of vaccines. <??>Advantages - human cells of the present invention can be cultured under defined serum free conditions, and the cells show improved capability for propagating virus. <??>In particular, methods are provided for producing in cultured human cells Influenza virus and vaccines derived thereof. This method eliminates the necessity to use whole chicken embryos for the production of Influenza vaccines. <??>The method provides also for the continuous or batchwise removal of culture media. As such, the present invention allows the large scale continuous production of viruses to a high titer.
Patent ES-2233284-T3 (ES)
Inventor: CAMPOS MANUEL
IPC: C07K7/23
Filed: 2000-02-14
Granted: 2005-06-16
Abstract: The subject invention provides a fusion protein for producing a dual immune response in a vertebrate, which fusion protein comprises: (a) a first proteinaceous portion analogous to all or part of a peptide endogenously synthesized within the vertebrate, the activity of which peptide is to be inhibited within the vertebrate, and which proteinaceous portion by itself is incapable of eliciting an effective immunoinhibitory response in said vertebrate; connected to (b) a second proteinaceous portion analogous to all or part of an immunogen from a pathogen, which pathogen is capable of pathogenically infecting the vertebrate; the portion (b) causing the vertebrate's immune system to recognize the portion (a) and produce a response that: (i) inhibits the activity of the peptide endogenously synthesized within the vertebrate; and (ii) protects the vertebrate from infection by the pathogen, when the vertebrate is vaccinated with an effective amount of the fusion protein. The subject invention also provides fusion proteins which comprise a proteinaceous portion (b) that is a carrier that is analogous to all or part of a BHV-1 antigen, which fusion proteins induce in a vertebrate vaccinated with an effective amount of such fusion protein an immune response that inhibits the activity of a peptide as recited in (a), above. <IMAGE>
Patent ES-2199125-T3 (ES)
Inventor: PHELY OLIVIER
IPC: B62D55/14
Filed: 2000-05-17
Granted: 2004-02-16
Abstract: The endless track drive comprising a flexible endless belt (22) with inwardly-facing teeth (24), main wheels (14, 16) at eac end and support wheels (20A, 20B, 20C, 20D). The novel feature is that a guide (50) is positioned between a main wheel and the adjac support wheel. This comprises two rollers (52) which contact the sides of each tooth to stabilise the belt.
Patent ES-2173072-T3 (ES)
Inventor: CANDAU DIDIER
IPC: A61K8/00
Filed: 2000-10-11
Granted: 2002-10-16
Abstract: A process for improving UV stability of at least one dibenzoylmethane derivative comprises addition of at least one insoluble organic UV filter in micronized form with average particle size 0.01-2 microns (preferably 0.03-1.0 microns) which can be obtained by grinding insoluble organic filter with larger particle size in presence of surfactant. An Independent claim is also included for use of insoluble organic UV-filter, in micronized form, in preparation of cosmetic or dermatological composition containing at least one dibenzoylmethane derivative, to improve UV-stability of this component.
Patent ES-2180503-T3 (ES)
Inventor: DUPLAIN JOCELYNE
IPC: B65D5/54
Filed: 2000-10-24
Granted: 2003-02-16
Abstract: Dispenser box (1) for paper bags with rigid handles (2a) has a parallelepiped body (1a) and a detachable lid (1b) attached by a pre-cut band (1c). The lid is made of panels forming an opening for the handles.
Patent ES-2265331-T3 (ES)
Inventor: COLLINS JOHN KEVIN
IPC: A61K39/00
Filed: 2000-01-17
Granted: 2007-02-16
Abstract: A strain of  Bifidobacterium  isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the prophylaxis and/or treatment of undesirable inflammatory activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer.
Patent ES-2208273-T3 (ES)
Inventor: KROPF CHRISTIAN
IPC: A61K8/00
Filed: 2000-01-29
Granted: 2004-06-16
Abstract: The invention relates to the use of nanoscale chitosanes and/or chitosane derivatives with particle diameters of 10 to 300 nm for producing cosmetic and/or pharmaceutical formulations. Compared to known chitosanes and chitosane derivatives, the particularly small size of the particles of the inventive chitosanes and chitosane derivatives ensures that when applied topically, they rapidly penetrate the stratum corneum of the skin or the keratin fibrillars of the hair.
Patent ES-2264927-T3 (ES)
Inventor: ROREGER MICHAEL
IPC: A61K8/02
Filed: 2000-03-09
Granted: 2007-02-01
Abstract: The invention relates to a dressing comprised of a support layer, a protective layer and of a pressure-sensitive adhesive layer for the controlled release of cosmetic active substances onto the skin. Said dressing is comprised of; 20-60 wt.% of at least one substance which provides adhesive properties to the layer; 4-40 wt.% of at least one structural polymer which provides inner cohesion and strength to the layer; 1-20 wt.% of at least one substance which enables an at least partial dissolution of a hydrophilic and/or lipophilic cosmetic active substance in an adhesive layer; 1-20 wt.% of at least one substance that promotes the absorption of a hydrophilic and/or lipophilic cosmetic active substance into the skin; and comprises 0.1 to 35 wt.% of at least one cosmetic active substance or of the preparation of at least one cosmetic active substance. The invention also relates the use of the dressing for moisturizing skin, for preventing the formation of wrinkles, for treating symptoms associated with aging of the skin, for treating pimples, for bleaching skin, for tightening skin or for regenerating and revitalizing skin.
Patent ES-2215629-T3 (ES)
Title: Mezcla pirorretardante que contiene pirorretardantes monomeros y oligomeros.
Inventor: BRADFORD LARRY L
IPC: C09K21/08
Filed: 2000-04-07
Granted: 2004-10-16
Abstract: Una mezcla pirorretardante que comprende: (a) un aditivo pirorretardante orgánico halogenado monómero que está adaptado para uso en una formulación de espuma de poliuretano; y (b) un aditivo pirorretardante de organofosfato oligómero que tiene un contenido de fósforo no inferior a 10%, en peso, y al menos tres unidades éster de fosfato en el mismo, siendo la cantidad de (a) en la mezcla no menor que la cantidad de (b).
Patent ES-2218149-T3 (ES)
Title: Procedimiento para la preparacion de material de poliuretano moldeado.
Inventor: BLEYS GERHARD JOZEF
IPC: B29K75/00
Filed: 2000-02-24
Granted: 2004-11-16
Abstract: Procedimiento para la preparación de un material de poliuretano en un molde, en cuyo procedimiento se llevan a cabo las siguientes etapas: 1. se aplica un agente desmoldeante externo sobre al menos aquellas superficies del molde que estarán en contacto con los ingredientes usados para la preparación del material de poliuretano y/o con el material de poliuretano acabado;
Patent ES-2216911-T3 (ES)
Inventor: GUSSALLI BERETTA UGO
IPC: F41A5/04
Filed: 2000-06-28
Granted: 2004-11-01
Abstract: This invention concerns a closing device for the barrel in semiautomatic and automatic pistols. The barrel (22) is equipped, in its lower rear part, with first lateral means (31) for interacting with the first complementary devices (28) at the sides of the breech-block (21) to hold the barrel closed when the breech-block is in the forward position, and with second means (32) designed to interact with the second complementary means (25) on an element (23) of the stock, for swinging the rear part of the barrel downward and the blocking of the barrel in order to open the gun when the breech-block is moved into the rear position.
Patent ES-2208399-T3 (ES)
Inventor: WIRTZ PETER
IPC: B01D39/20
Filed: 2000-07-05
Granted: 2004-06-16
Abstract: The invention relates to a plane metal structure which is especially useful for filtration. A metal fibre yarn is incorporated between the metal wires. The metal wire provides sufficient solidity for the plane structure. The metal fibre yarn is an excellent material for deep-bed filtration. In a preferred embodiment, the metal wire is woven together with the metal fibre yarn to form a tissue. The metal fibre yarn forms the weft and the metal wire the chain.
Patent ES-2222942-T3 (ES)
Inventor: ANTILA MIKA
IPC: G09G5/00
Filed: 2001-10-31
Granted: 2005-02-16
Abstract: A method and a display system for updating image frames on a display screen of the display system. In the system, image frames comprising a frame and line synchronization signal are transferred from a control system to a display unit. The display unit comprises a display screen for displaying image frames, a frame buffer for buffering the image frames before they are transferred via a transfer bus to the screen, and a display interface for receiving image frames from the control system to the frame buffer. A frame and line synchronization signal are coupled to the control system from an image frame to be updated to the screen, and the control system is timed based on pulses comprised by the frame and line synchronization signal to input a new image frame to the frame buffer such that the new image frame is not stored onto the image frame being updated. <IMAGE>
Patent ES-2241715-T3 (ES)
Inventor: RENZ WALTER DIPL-ING
IPC: E05D15/10
Filed: 2001-05-18
Granted: 2005-11-01
Abstract: The running carriage (6,6a) is for a parallel slide or tip fitting for a building window or building window door. It is fixed in the area of a lower horizontal rail (5') of a pane frame (5) and has at least two outer first components (7,8, 7a,8a) in the area of one end of the lower horizontal rail of the pane frame and fix via a bearing.   At least one running shoe is provided, which on a housing has several rollers working in conjunction with a running rail. At least one additional second running carriage component (9,10, 9a,10a) is fixable to the rail of the pane frame with its own bearings and has a running shoe and carriage rollers. The running shoe of the second carriage component is connected via at least one connecting member with the running shoe of the first running carriage components.
Patent ES-2280297-T3 (ES)
Inventor: MULLER ERHARD
IPC: A61L17/10
Filed: 2001-12-15
Granted: 2007-09-16
Abstract: A suture material for surgery comprises one or more filaments and is formed with a coating, which is characterized in that the coating at least partly comprises a bioresorbable polymer, which is essentially formed from a random terpolymer with a completely amorphous structure.
Patent ES-2201015-T3 (ES)
Inventor: TER BRAAK BART
IPC: B29C45/00
Filed: 2001-01-11
Granted: 2004-03-16
Abstract: A method for manufacturing at least one plastic curtain glider (201) comprising a body (206) and a substantially U-shaped eye (203,204,205) which has two legs (203,204) connected with the body (206) and an arch portion (205) connecting the legs (203,204) with each other at the ends remote from the body (206), the glider being manufactured by means of an injection molding process in an injection mold which is provided with at least one injection mold cavity (100) containing at least one glider cavity (101), the plastic being injected into the glider cavity (101) from such a position that plastic streams (A,B,C,D,E,F) formed in the glider cavity (101) during the injection do not meet each other in the arch portion (205) of the U-shaped eye (203,204,205). The invention also relates to an injection mold for use in the method and to a glider and glider strip obtained by means of the method, using the injection mold. <IMAGE>
Patent ES-2284583-T3 (ES)
Inventor: DE HAAN BEN RUDOLF
IPC: A23C19/16
Filed: 2001-01-31
Granted: 2007-11-16
Abstract: A method for the preparation of a cheese is disclosed, wherein a cheese is provided with a cheese coating by providing said cheese with a homogeneous coating solution, which is produced in-line with the production of the actual coating on the cheese. The cheese coating is formulated on the basis of the produced cheese and/or phase in the ripening of the cheese. The coating solution is generated by mixing a number of components at least one of which comprises a viscosity of at least 4000 mPa.s. The method further comprising mixing components of said coating solution into a coating solution in a process that substantially avoids the introduction of gas bubbles.
Patent ES-2207592-T3 (ES)
Inventor: FRANKEFORT PETRUS WILHELMUS MA
IPC: B65C3/06
Filed: 2001-04-19
Granted: 2004-06-01
Abstract: Device for fitting a sleeve (1) onto a container (14) such as a bottle or a similar object, means being provided for pulling a plastic tube from a supply roller from which a sleeve (1) is cut-off. The device comprises a number of double-walled bushes (2), each being provided with a guiding member (17) and consisting of a perforated inner wall (3) and an outer wall (4) extending around said inner wall so that an annular space (5) is formed, in which underpressure can be generated through a vacuum line (22). There are positioning means (19, 20) for the bushes, so that a sleeve (1) can be slid into it and can engage the inner wall (3) of the bush, whereupon the bush is slid across a container (14) and the connection to the vacuum line (22) is removed. Then the bush is brought upwards and the container can be removed from the device. <IMAGE>
Patent ES-2249384-T3 (ES)
Inventor: BAKTHAVATCHALAM RAJAGOPAL
IPC: C07D487/10
Filed: 2001-12-11
Granted: 2006-04-01
Abstract: Substituted spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4'-piperidines capable of modulating NPY5 receptor activity are provided. Such compounds may be used to modulate ligand binding to NPY5 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of disorders (e.g., eating disorders such as obesity or bulimia, psychiatric disorders, diabetes and cardiovascular disorders such as hypertension) in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such compounds for detecting NPY5 receptors.
Patent ES-2252163-T3 (ES)
Title: Composicion de polimero pvc libre de plomo.
Inventor: HJORT DELGADO ARTURO
IPC: C08K5/01
Filed: 2001-11-22
Granted: 2006-05-16
Abstract: La utilización de fosfito de tris(2, 4-di-tert- butilfenilo) como agente quelante en un cable de automoción de pared delgada que tiene una composición de envainado y de aislamiento de poli(cloruro de vinilo) que no contiene plomo, comprendiendo dicha composición de aislamiento y envainado una mezcla de: a) de 60 a 100 partes en peso de una resina de poli(cloruro de vinilo); b) de 3 a 6 partes en peso de un estabilizador de cinc; c) de 15 a 40 partes en peso de un plastificante de tipo co-éster lineal de 9 a 11 átomos de carbono; d) de 10 a 40 partes en peso de una carga de carbonato de calcio de 1 micrómetro; e) de 3 a 6 partes en peso de un anti-oxidante de tipo fenol; y f) de 1 a 4 partes en peso de un lubricante de tipo polietileno oxidado; en la que el fosfito de tris(2, 4-di-tert-butilfenilo) actúa como co-estabilizador para regenerar el metal estabilizador, prolongando de este modo la acción de estabilización del estabilizador.
Patent ES-2240421-T3 (ES)
Title: Composiciones de acondicionamiento de tejidos.
Inventor: CAHILL GARY
IPC: C11D3/00
Filed: 2001-01-22
Granted: 2005-10-16
Abstract: Composición de acondicionamiento de tejidos que comprende un compuesto catiónico de suavizado de tejidos, de amonio cuaternario con enlaces éster, disperso en agua, teniendo el agua disuelto en ella al menos un sulfato de metal alcalino o de metal alcalinotérreo.
Patent ES-2394294-T3 (ES)
Title: Un sistema de medición de servicios que incorpora un sistema de autorización de transacciones
Inventor: JARMAN MICHAEL
IPC: G07F15/06
Filed: 2001-05-18
Granted: 2013-01-30
Abstract: Un sistema de autorización de transacciones caracterizado por: una unidad (30) de interfaz de usuario capazde aceptar entradas de usuario en una transacción y que incluye un dispositivo (34) lector de tarjetas; y, uncontador (10) de servicios provisto en una ubicación que tiene un identificador de ubicación único asociado a laubicación, en el que el dispositivo (35) lector de tarjetas está dispuesto para leer datos desde una tarjeta a la quese cargará la transacción, en el que el contador (10) de servicios y la unidad (30) de interfaz de usuario estándispuestos para comunicarse, para generar una solicitud de autorización de transacción en base a las entradas deusuario en la transacción, a los datos de la tarjeta leída por el dispositivo (35) lector de tarjetas y al identificador deubicación, y para transmitir la solicitud de autorización de transacción a una autoridad (40) de autorización remotapara obtener autorización de la transacción.
Patent ES-2290151-T3 (ES)
Title: Reduccion del crecimiento del pelo.
Inventor: STYCZYNSKI PETER
IPC: A61K31/445
Filed: 2001-01-23
Granted: 2008-02-16
Abstract: Un método no terapéutico de reducir el creci-miento del pelo en los mamíferos que comprende: seleccionar una zona de la piel de la cual se desea reducir el creci-miento del pelo; y aplicar a dicha zona de la piel una com-posición dermatológicamente aceptable que comprende un com-puesto que incrementa los niveles de ceramida celular en una cantidad eficaz para reducir el crecimiento del pelo seleccionado de: inhibidores de la glucosilceramida sintasa, seleccio-nados a partir de 1-fenil-2-decanoil-amino-3-morfolino-1-propanol, 1-fenil-2-hexadecanoil-amino-3-morfolino-1-propa-nol, 1-fenil-2-hexadecanoil-amino-3-pirrolidino-1-propanol, 1-fenil-2-palmitoilamino-3-pirrolidino-1-propanol, D-treo-4''-hidroxi-1-fenil-2-palmitoilamino-3-pirrolidino-1-propa-nol, D-treo-3'', 4''-metilenodioxifenil-1-fenil-2-palmitoila-mino-3-pirrolidino-1-propanol, D-treo-trimetilenodioxife-nil-1-fenil-2-palmitoilamino-3-pirrolidino-1-propanol, D-treo-3'', 4''-etilenodioxifenil-1-fenil-2-palmitoilamino-3-pi-rrolidino-1-propanol; N-butildesoxinojirimicina (NBDN); y N-(5-adamantano)-1-il-metoxi)pentil)-desoxinorjirimicina; inhibidores de la ceramidasa; ceramida; compuestos análogos de la ceramida seleccionados de N-hexanoilesfingosina, N-octanoilesfingosina, N-octanoil-DL-eritro dihidroesfingosina, N-octil-D-eritro-esfingosina, N-tioacetilesfingosina, 4-dodecanoilamino-decan-5-ol, y N-acetilesfingosina; y compuestos inductores de la esfingomielinasa.
Patent ES-2273867-T3 (ES)
Inventor: TALBOT PIERRE
IPC: B01J19/24
Filed: 2001-07-12
Granted: 2007-05-16
Abstract: An oriented structure for treating a fluid, comprising an inlet end for receiving a fluid to be treated and an outlet end opposite the inlet end and from which a treated fluid is discharged, the fluid being allowed to flow into the structure from the inlet end to the outlet end defining a flowing direction. The oriented structure comprises a juxtaposition of layers of porous material having a different porosity, each layer spanning from the inlet end to the outlet end of the structure whereby in use the layers are oriented generally parallel to the flowing direction of the fluid. The oriented structure is designed so to better control the different biological and physical phenomena related to the accumulation or exchange processes taking place in the structure.
Patent ES-2276809-T3 (ES)
Inventor: SCHUSTER KILLIAN
IPC: B66B13/22
Filed: 2001-08-02
Granted: 2007-07-01
Abstract: A monitoring device for an elevator includes a plurality of switching devices connected in a series safety chain. Each switching device has an active unit generating a pattern and a passive unit that responds to the pattern within a defined spacing between the units.
Patent ES-2519440-T3 (ES)
Title: Vacunas para la protección de amplio espectro contra enfermedades causadas por Neisseria meningitidis
Inventor: GRANOFF DAN
IPC: C07K16/12
Filed: 2001-07-27
Granted: 2014-11-07
Abstract: Una primera, una segunda y una tercera preparación para su uso en un método de tratamiento de un mamífero, en donde dicho tratamiento provoca una inmunidad de amplio espectro contra una enfermedad causada por una cepa de Neisseria meningitidis, en donde dicha primera preparación comprende vesículas de membrana externa (VME), microvesículas (MV) o tanto VME como MV de una primera cepa de Neisseria meningitidis que es un miembro de un primer serogrupo, un primer serotipo y un primer serosubtipo, en donde dicha segunda preparación comprende las VME, las MV o tanto las VME como las MV de una segunda cepa de Neisseria meningitidis que es un miembro de un segundo serogrupo, un segundo serotipo y un segundo serosubtipo, en donde dicha tercera preparación comprende las VME, las MV o tanto las VME como las MV de una tercera cepa de Neisseria meningitidis que es un miembro de un tercer serogrupo, un tercer serotipo y un tercer serosubtipo, y en donde el serogrupo, el serotipo y el serosubtipo de la primera, la segunda y la tercera cepa de Neisseria meningitidis son diferentes, y en donde la primera, la segunda y la tercera preparación se usan en una cantidad suficiente para provocar una respuesta inmunitaria contra epítopes presentes en dichas preparaciones; comprendiendo el método la administración en serie de la primera, la segunda y la tercera preparación, de tal manera que la segunda preparación se administra después de que dicho mamífero se haya sensibilizado inmunológicamente por exposición a la primera preparación y la tercera preparación se administra después de que dicho mamífero se haya sensibilizado inmunológicamente por exposición a la segunda preparación, en donde la administración de la primera, la segunda y la tercera preparación es suficiente para provocar una respuesta inmunitaria en dicho mamífero, confiriendo dicha respuesta inmunitaria inmunoprotección contra una enfermedad causada por al menos una cepa de Neisseria meningitidis, y en donde dichas primera, segunda y tercera preparaciones son eficaces para provocar una respuesta de anticuerpos bactericida contra al menos una cepa de Neisseria meningitidis que expresa un epítope del serosubtipo no incluido en la primera, la segunda o la tercera preparación.